Cases of PMD resulting from point mutations in SHANK3 have increased in recent years due to the prevalence of more large-scale sequencing studies (Sarasua et al., 2011; Soorya et al., 2013; De Rubeis et al., 2018). The gene discussed is SHANK3; the disease is Pelizeaus-Merzbacher spectrum disorder.